4.8 Article

Platelet-Like Fusogenic Liposome-Mediated Targeting Delivery of miR-21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia-Reperfusion Injury

期刊

ADVANCED SCIENCE
卷 8, 期 15, 页码 -

出版社

WILEY
DOI: 10.1002/advs.202100787

关键词

Biomimetic; macrophages; membrane fusion; miRNAs; monocytes; myocardial ischemia-reperfusion injury; platelets

资金

  1. National Natural Science Foundation of China [82070281, 81801374]

向作者/读者索取更多资源

A platelet-like fusogenic liposome (PLPs) was developed to deliver mesoporous silica nanospheres loaded with anti-inflammatory agent miR-21 to the inflammatory monocytes in MI/R induced mice, achieving reparative reprogramming of inflamed macrophages and preserving cardiac function effectively. This nano-platform shows promise as a minimally invasive and biologically safe approach for immunotherapy.
Inflammatory modulations focusing on macrophage phenotype are promising candidates to promote better cardiac healing post myocardial ischemia-reperfusion (MI/R) injury. However, the peak of monocyte/macrophage recruitment is later than the time when enhanced permeability and retention effect disappears, which greatly increases the difficulty of reprogramming macrophages through systemic administration. Meanwhile, the inability of nanomaterials to release their contents to specific intracellular locations through reasonable cellular internalization pathways is another obstacle to achieving macrophage reprogramming. Here, inspired by the increase in circulating platelet-monocyte aggregates in patients ' post-MI/R and the high efficiency of fusogenic liposomes to deliver contents to the cytoplasm of target cells, a platelet-like fusogenic liposome (PLPs) is constructed. Under the coating of PLPs, mesoporous silica nanospheres with a payload of miR-21, an anti-inflammatory agent, can be specifically delivered to inflammatory monocytes in the blood circulation of MI/R induced mice. Then it directly enters the cytoplasm of monocytes through membrane fusion, thereby realizing the reparative reprogramming of the inflamed macrophages derived from it. In vivo administration of the resulting formula can effectively preserve the cardiac function of mice undergone MI/R. Minimal invasiveness and biological safety make this nano-platform a promising approach of immunotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据